Clinical trial
Intravenous Tenecteplase for Acute Ischemic Stroke With Unknown Time of Onset Under Non-Contrast CT Selection: A Multicenter, Prospective, Randomized, Open-label, Blinded Endpoint Trial
NCT07475949 is registered in ClinicalTrials.gov with First Affiliated Hospital of Guangxi Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Tenecteplase for Acute Ischemic Stroke With Unknown Time of Onset Under Non-Contrast CT Selection: A Multicenter, Prospective, Randomized, Open-label, Blinded Endpoint Trial
- Lead sponsor
- First Affiliated Hospital of Guangxi Medical University
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- September 24, 2026
- Completion date
- December 31, 2028
- Enrollment
- 352 (estimated)
- Sites
- 15
Conditions
As the registry lists them; a condition with its own page is linked.
acute ischemic stroke, tenecteplase